"Lung Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the LUNG.
Descriptor ID |
D008175
|
MeSH Number(s) |
C04.588.894.797.520 C08.381.540 C08.785.520
|
Concept/Terms |
Lung Neoplasms- Lung Neoplasms
- Pulmonary Neoplasms
- Neoplasms, Lung
- Lung Neoplasm
- Neoplasm, Lung
- Neoplasms, Pulmonary
- Neoplasm, Pulmonary
- Pulmonary Neoplasm
Lung Cancer- Lung Cancer
- Cancer, Lung
- Cancers, Lung
- Lung Cancers
- Pulmonary Cancer
- Cancer, Pulmonary
- Cancers, Pulmonary
- Pulmonary Cancers
- Cancer of the Lung
- Cancer of Lung
|
Below are MeSH descriptors whose meaning is more general than "Lung Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Lung Neoplasms".
This graph shows the total number of publications written about "Lung Neoplasms" by people in this website by year, and whether "Lung Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 44 | 14 | 58 |
1996 | 45 | 17 | 62 |
1997 | 48 | 19 | 67 |
1998 | 47 | 22 | 69 |
1999 | 51 | 10 | 61 |
2000 | 70 | 20 | 90 |
2001 | 73 | 29 | 102 |
2002 | 98 | 23 | 121 |
2003 | 117 | 28 | 145 |
2004 | 112 | 37 | 149 |
2005 | 111 | 33 | 144 |
2006 | 119 | 19 | 138 |
2007 | 135 | 34 | 169 |
2008 | 156 | 32 | 188 |
2009 | 120 | 33 | 153 |
2010 | 156 | 37 | 193 |
2011 | 192 | 34 | 226 |
2012 | 180 | 28 | 208 |
2013 | 182 | 31 | 213 |
2014 | 196 | 24 | 220 |
2015 | 187 | 25 | 212 |
2016 | 176 | 22 | 198 |
2017 | 185 | 34 | 219 |
2018 | 212 | 32 | 244 |
2019 | 187 | 19 | 206 |
2020 | 229 | 21 | 250 |
2021 | 226 | 5 | 231 |
2022 | 196 | 3 | 199 |
2023 | 212 | 2 | 214 |
2024 | 152 | 24 | 176 |
2025 | 6 | 1 | 7 |
To return to the timeline,
click here.
Below are the most recent publications written about "Lung Neoplasms" by people in Profiles.
-
Examining Lung Cancer Screening Uptake in the United States: Recent Research and Limitations of Public-Use Data. Cancer Epidemiol Biomarkers Prev. 2025 Jan 09; 34(1):9-11.
-
Robust Bayesian graphical regression models for assessing tumor heterogeneity in proteomic networks. Biometrics. 2025 Jan 07; 81(1).
-
Occult metastases and survival of lung cancer by clinical diagnosis and CT screening: A simulation study. PLoS One. 2025; 20(1):e0313544.
-
Complement factor H targeting antibody GT103 in refractory non-small cell lung cancer: a phase 1b dose escalation trial. Nat Commun. 2025 Jan 02; 16(1):93.
-
Application of a digital quality measure for cancer diagnosis in Epic Cosmos. J Am Med Inform Assoc. 2025 Jan 01; 32(1):227-229.
-
A rapid turnaround time workflow for a cytological liquid biopsy assay using FNA supernatant specimens. Cancer Cytopathol. 2025 Jan; 133(1):e22925.
-
Pan-cancer genomic analysis reveals FOXA1 amplification is associated with adverse outcomes in non-small cell lung, prostate, and breast cancers. J Natl Cancer Inst. 2025 Jan 01; 117(1):188-197.
-
High peripheral T cell diversity is associated with lower risk of toxicity and superior response to dual immune checkpoint inhibitor therapy in patients with metastatic NSCLC. J Immunother Cancer. 2024 Dec 25; 12(12).
-
Toripalimab plus chemotherapy for first line treatment of advanced non-small cell lung cancer (CHOICE-01): final OS and biomarker exploration of a randomized, double-blind, phase 3 trial. Signal Transduct Target Ther. 2024 Dec 24; 9(1):369.
-
Overexpression of ELF3 in the PTEN-deficient lung epithelium promotes lung cancer development by inhibiting ferroptosis. Cell Death Dis. 2024 Dec 18; 15(12):897.